Explore Moderna's Q1 2025 financial performance, revealing key sales, losses, and strategic recommendations for investors amid evolving market dynamics.
Explore Moderna, Inc.'s 2024 financial report highlighting $8.362B revenue, $3.607B loss, and R&D prospects. Investors advised to hold amid market challenges.
Discover crucial details from Moderna's 8-K filing on January 13, 2025, highlighting significant corporate events and insights for investors. Ticker: MRNA.
Explore BioNTech SE's financial report detailing a $467M royalty settlement with the University of Pennsylvania, including Pfizer's $170M reimbursement and key agreement terms.
Explore BioNTech SE's Form 6-K report detailing a $791.5M settlement with the NIH over COVID-19 vaccine royalties and new licensing terms effective January 2024.